These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8780464)

  • 1. Atovaquone in the treatment of Babesia microti infections in hamsters.
    Wittner M; Lederman J; Tanowitz HB; Rosenbaum GS; Weiss LM
    Am J Trop Med Hyg; 1996 Aug; 55(2):219-22. PubMed ID: 8780464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atovaquone and azithromycin for the treatment of babesiosis.
    Krause PJ; Lepore T; Sikand VK; Gadbaw J; Burke G; Telford SR; Brassard P; Pearl D; Azlanzadeh J; Christianson D; McGrath D; Spielman A
    N Engl J Med; 2000 Nov; 343(20):1454-8. PubMed ID: 11078770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
    Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
    Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful prevention and treatment of babesiosis with atovaquone.
    Hughes WT; Oz HS
    J Infect Dis; 1995 Oct; 172(4):1042-6. PubMed ID: 7561178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
    Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G
    Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts.
    Tuvshintulga B; Sivakumar T; Nugraha AB; Ahedor B; Batmagnai E; Otgonsuren D; Liu M; Xuan X; Igarashi I; Yokoyama N
    J Infect Dis; 2022 Jan; 225(2):238-242. PubMed ID: 34664651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of babesiosis.
    Ranque S
    N Engl J Med; 2001 Mar; 344(10):773-4. PubMed ID: 11236790
    [No Abstract]   [Full Text] [Related]  

  • 8. Babesiosis in humans: a treatment review.
    Weiss LM
    Expert Opin Pharmacother; 2002 Aug; 3(8):1109-15. PubMed ID: 12150690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
    Gray JS; Pudney M
    J Parasitol; 1999 Aug; 85(4):723-8. PubMed ID: 10461956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone.
    Kletsova EA; Spitzer ED; Fries BC; Marcos LA
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):26. PubMed ID: 28399851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of azithromycin for treating Babesia microti infection in the hamster model.
    Weiss LM; Wittner M; Wasserman S; Oz HS; Retsema J; Tanowitz HB
    J Infect Dis; 1993 Nov; 168(5):1289-92. PubMed ID: 8228366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens.
    Pudney M; Gray JS
    J Parasitol; 1997 Apr; 83(2):307-10. PubMed ID: 9105316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia.
    Simon MS; Westblade LF; Dziedziech A; Visone JE; Furman RR; Jenkins SG; Schuetz AN; Kirkman LA
    Clin Infect Dis; 2017 Oct; 65(7):1222-1225. PubMed ID: 28541469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of babesiosis.
    Weiss LM; Wittner M; Tanowitz HB
    N Engl J Med; 2001 Mar; 344(10):773. PubMed ID: 11236789
    [No Abstract]   [Full Text] [Related]  

  • 15. Atovaquone and azithromycin treatment for babesiosis in an infant.
    Raju M; Salazar JC; Leopold H; Krause PJ
    Pediatr Infect Dis J; 2007 Feb; 26(2):181-3. PubMed ID: 17259886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone plus cholestyramine in patients coinfected with Babesia microti and Borrelia burgdorferi refractory to other treatment.
    Shoemaker RC; Hudnell HK; House DE; Van Kempen A; Pakes GE;
    Adv Ther; 2006; 23(1):1-11. PubMed ID: 16644602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misdiagnosis of Babesiosis as Malaria, Equatorial Guinea, 2014.
    Arsuaga M; González LM; Padial ES; Dinkessa AW; Sevilla E; Trigo E; Puente S; Gray J; Montero E
    Emerg Infect Dis; 2018 Aug; 24(8):1588-1589. PubMed ID: 30016247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent babesiosis in a stem cell transplant recipient.
    Lubin AS; Snydman DR; Miller KB
    Leuk Res; 2011 Jun; 35(6):e77-8. PubMed ID: 21185598
    [No Abstract]   [Full Text] [Related]  

  • 19. Response of babesiosis to a combined regimen of quinine and azithromycin.
    Shaio MF; Yang KD
    Trans R Soc Trop Med Hyg; 1997; 91(2):214-5. PubMed ID: 9196774
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report.
    Vyas JM; Telford SR; Robbins GK
    Clin Infect Dis; 2007 Dec; 45(12):1588-90. PubMed ID: 18190320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.